Robert F. Kennedy Jr. is appearing before the Senate Finance Committee to discuss the details of President Trump’s proposed 2026 health care agenda. The plan includes measures to reform the healthcare system with an emphasis on cost reduction, innovation, and improved patient outcomes. During his testimony, Kennedy is also addressing recent changes in the leadership of the Centers for Disease Control and Prevention (CDC), which has sparked debate among lawmakers and public health experts.
Kennedy’s testimony comes as part of ongoing congressional scrutiny of the Trump administration’s healthcare policies. The changes at the CDC, including the replacement of its director, have raised concerns about the continuity of public health initiatives and the potential impact on pandemic preparedness. Lawmakers are closely examining how these changes could affect the nation’s healthcare infrastructure and public health response strategies.